» » VITROS® XT 7600 Integrated System from Ortho Clinical Diagnostics Receives CE Mark, Bringing Innovative New Approach to Clinical Lab Management

VITROS® XT 7600 Integrated System from Ortho Clinical Diagnostics Receives CE Mark, Bringing Innovative New Approach to Clinical Lab Management

Novel diagnostic technology enables powerful data intelligence, operational improvements and other enhancements in the lab

RARITAN, New Jersey, July 25, 2018 /PRNewswire/ — Ortho Clinical Diagnostics today announced that it has received CE mark for Ortho’s VITROS® XT 7600 Integrated System. By combining Ortho’s proprietary dry slide technology with sophisticated digital imaging capabilities and the potential to perform two separate lab tests simultaneously, Ortho is introducing digital chemistry to clinical lab management.  Digital chemistry brings powerful data intelligence, operational improvements and heightened quality to the lab to help clinical laboratories keep pace with a rapidly evolving global health care environment, without requiring additional lab space.

VITROS® XT 7600 Integrated System from Ortho Clinical Diagnostics

“Ortho’s VITROS® XT 7600 harnesses the power of our proprietary dry slide technology to deliver even more enhanced, high-quality test results, higher throughput and an improved patient experience, all within the lab’s existing physical footprint,” said Robert Yates, chief operating officer of Ortho Clinical Diagnostics. “It’s a fundamental change to the way labs operate.”

The digital chemistry behind Ortho’s VITROS® XT 7600 is based on three enabling technologies:

  • Dry slide technology.  Unlike traditional wet chemistry systems, which require highly purified water and complex plumbing systems to operate, Ortho’s proprietary dry slide technology does not require water to run.  This eliminates the risk that poor water quality could impact test results.
  • MicroSlide.   A full testing environment on a postage-stamp-sized piece of film enables precise and accurate testing in a waterless environment.
  • Digital imaging technology.  Advanced optics glean significantly more information from testing than has been possible to date, enabling better precision and powerful data intelligence functions in the lab.

In addition, Ortho’s VITROS® XT 7600 increases productivity, with less patient blood sample required, by introducing multi-test processing – the potential to offer two tests per slide instead of one — to clinical chemistry. With XT MicroSlides1, the instrument will provide the ability to pair tests that are frequently ordered for the same patient so they can be run simultaneously. This saves time and space in the lab, and reduces the amount of blood needed for testing, an important advantage for vulnerable patients or those with venous access issues.

“We are an internationally renowned laboratory where quality comes first. The Ortho technology is stable and filters out most common interferences to deliver a high first-pass yield and minimal reruns,” said Phil Craddock-Jones, lab manager, Sheffield Children’s Hospital in the UK. “Ortho’s VITROS® Systems don’t require water to run, which reduces the risk of water contamination.”

The Ortho VITROS® XT 7600 Integrated System has received CE Mark signifying conformance to applicable European Union regulatory requirements and is now available for purchase in numerous countries in Europe, the Middle East, Africa, Asia and Latin America.

About Ortho’s VITROS® Systems
The VITROS® Chemistry, Immunodiagnostics and Integrated Systems from Ortho Clinical Diagnostics is a portfolio of products and patented enabling technologies which help clinical laboratories diagnose, monitor and treat disease.  VITROS® Products are engineered to help clinical laboratories with organizational, operational and economic challenges.

About Ortho Clinical Diagnostics
Ortho Clinical Diagnostics is a global leader of in vitro diagnostics serving the clinical laboratory and immunohematology communities. Across hospitals, hospital networks, blood banks and labs in more than 125 countries and territories, Ortho’s high-quality products and services enable health care professionals to make better-informed treatment decisions. For the immunohematology community, Ortho’s blood typing products help ensure every patient receives blood that is safe, the right type and the right unit. Ortho brings sophisticated testing technologies, automation, information management and interpretation tools to clinical laboratories around the world to help them run more efficiently and effectively and improve patient care. Ortho’s purpose is to improve and save lives with diagnostics, and it does that by reimagining what’s possible. This is what has defined Ortho for more than 75 years, and it’s what drives Ortho forward. For more information, visit www.orthoclinicaldiagnostics.com.

© Ortho Clinical Diagnostics 2018

PR-03960

1 Under development

Photo – https://mma.prnewswire.com/media/721917/Ortho_Clinical_Diagnostics_XT7600.jpg
Logo – https://mma.prnewswire.com/media/699913/Ortho_Clinical_Diagnostics_Logo.jpg

Asianet PakistanPress Release
Novel diagnostic technology enables powerful data intelligence, operational improvements and other enhancements in the lab RARITAN, New Jersey, July 25, 2018 /PRNewswire/ — Ortho Clinical Diagnostics today announced that it has received CE mark for Ortho’s VITROS® XT 7600 Integrated System. By combining Ortho’s proprietary dry slide technology with sophisticated...

Related Categorized Posts

استقالة الرئيسة التنفيذية لمؤسسة بيل ومليندا غيتس سو ديزموند هيلمان؛ تعيين العضو التنفيذي القديم في المؤسسة مارك سوزمان رئيسا تنفيذيا للمؤسسة
سياتل، 6 كانون الأول/ديسمبر، 2019 / بي آر نيوزواير / — أعلنت الرئيسة التنفيذية لمؤسسة بيل ومليندا غيتس سو ديزموند هيلمان تنحيها عن رئاسة المؤسسة بعد خمس سنوات من...

مستقبل يمكن توقعه: مجتمع العلوم والتقنية يعرب عن آمال كبيرة في التعاون مع الأتراب في الصين
بكين، 6 كانون الأول/ديسمبر، 2019 / بي آر نيوزواير / — يصادف حلول العام 2019 الذكرى السبعين لتأسيس جمهورية الصين الشعبية. وانتهزت مجلة العلوم والتكنولوجيا ديلي الفرصة لإجراء مقابلات...

‫مجموعة “جميرا” تضيف “كابري بالاس” في إيطاليا إلى قائمة فنادقها العالمية

‫مجموعة “جميرا” تضيف “كابري بالاس” في إيطاليا إلى قائمة فنادقها العالمية
 أعلنت مجموعة “جميرا”، الشركة العالمية الرائدة في إدارة الفنادق الفاخرة والتابعة لدبي القابضة، اليوم عن اختيارها لتشغيل وإدارة فندق “كابري بالاس” الشهير في إيطاليا. ولمشاهدة بيانات المالتى ميديا الصحفية...

مايندتري تنال جائزة اتحاد جنوب آسيا للمحاسبين عن أفضل تقرير سنوي مقدم

مايندتري تنال جائزة اتحاد جنوب آسيا للمحاسبين عن أفضل تقرير سنوي مقدم
 تكريم الشركة في فئة “قطاع الاتصالات وتقنية المعلومات” وارين، نيوجيرسي وبنغالور، الهند، 5 ديسمبر/كانون أول، 2019 /PRNewswire/ — حازت مايندتري “Mindtree“، الشركة العالمية الرائدة في مجال التقنية والتحول الرقمي،...

Bill & Melinda Gates Foundation CEO Sue Desmond-Hellmann to Step Down, Longtime Foundation Executive Mark Suzman Appointed to Role
SEATTLE, Dec. 5, 2019 /PRNewswire/ — Bill & Melinda Gates Foundation CEO Sue Desmond-Hellmann is stepping down after more than five years in the role. Bill and Melinda Gates have...

VITROS® XT 7600 Integrated System from Ortho Clinical Diagnostics Receives CE Mark, Bringing Innovative New Approach to Clinical Lab Management

Novel diagnostic technology enables powerful data intelligence, operational improvements and other enhancements in the lab

RARITAN, New Jersey, July 25, 2018 /PRNewswire/ — Ortho Clinical Diagnostics today announced that it has received CE mark for Ortho’s VITROS® XT 7600 Integrated System. By combining Ortho’s proprietary dry slide technology with sophisticated digital imaging capabilities and the potential to perform two separate lab tests simultaneously, Ortho is introducing digital chemistry to clinical lab management.  Digital chemistry brings powerful data intelligence, operational improvements and heightened quality to the lab to help clinical laboratories keep pace with a rapidly evolving global health care environment, without requiring additional lab space.

VITROS® XT 7600 Integrated System from Ortho Clinical Diagnostics

“Ortho’s VITROS® XT 7600 harnesses the power of our proprietary dry slide technology to deliver even more enhanced, high-quality test results, higher throughput and an improved patient experience, all within the lab’s existing physical footprint,” said Robert Yates, chief operating officer of Ortho Clinical Diagnostics. “It’s a fundamental change to the way labs operate.”

The digital chemistry behind Ortho’s VITROS® XT 7600 is based on three enabling technologies:

  • Dry slide technology.  Unlike traditional wet chemistry systems, which require highly purified water and complex plumbing systems to operate, Ortho’s proprietary dry slide technology does not require water to run.  This eliminates the risk that poor water quality could impact test results.
  • MicroSlide.   A full testing environment on a postage-stamp-sized piece of film enables precise and accurate testing in a waterless environment.
  • Digital imaging technology.  Advanced optics glean significantly more information from testing than has been possible to date, enabling better precision and powerful data intelligence functions in the lab.

In addition, Ortho’s VITROS® XT 7600 increases productivity, with less patient blood sample required, by introducing multi-test processing – the potential to offer two tests per slide instead of one — to clinical chemistry. With XT MicroSlides1, the instrument will provide the ability to pair tests that are frequently ordered for the same patient so they can be run simultaneously. This saves time and space in the lab, and reduces the amount of blood needed for testing, an important advantage for vulnerable patients or those with venous access issues.

“We are an internationally renowned laboratory where quality comes first. The Ortho technology is stable and filters out most common interferences to deliver a high first-pass yield and minimal reruns,” said Phil Craddock-Jones, lab manager, Sheffield Children’s Hospital in the UK. “Ortho’s VITROS® Systems don’t require water to run, which reduces the risk of water contamination.”

The Ortho VITROS® XT 7600 Integrated System has received CE Mark signifying conformance to applicable European Union regulatory requirements and is now available for purchase in numerous countries in Europe, the Middle East, Africa, Asia and Latin America.

About Ortho’s VITROS® Systems
The VITROS® Chemistry, Immunodiagnostics and Integrated Systems from Ortho Clinical Diagnostics is a portfolio of products and patented enabling technologies which help clinical laboratories diagnose, monitor and treat disease.  VITROS® Products are engineered to help clinical laboratories with organizational, operational and economic challenges.

About Ortho Clinical Diagnostics
Ortho Clinical Diagnostics is a global leader of in vitro diagnostics serving the clinical laboratory and immunohematology communities. Across hospitals, hospital networks, blood banks and labs in more than 125 countries and territories, Ortho’s high-quality products and services enable health care professionals to make better-informed treatment decisions. For the immunohematology community, Ortho’s blood typing products help ensure every patient receives blood that is safe, the right type and the right unit. Ortho brings sophisticated testing technologies, automation, information management and interpretation tools to clinical laboratories around the world to help them run more efficiently and effectively and improve patient care. Ortho’s purpose is to improve and save lives with diagnostics, and it does that by reimagining what’s possible. This is what has defined Ortho for more than 75 years, and it’s what drives Ortho forward. For more information, visit www.orthoclinicaldiagnostics.com.

© Ortho Clinical Diagnostics 2018

PR-03960

1 Under development

Photo – https://mma.prnewswire.com/media/721917/Ortho_Clinical_Diagnostics_XT7600.jpg
Logo – https://mma.prnewswire.com/media/699913/Ortho_Clinical_Diagnostics_Logo.jpg

Asianet PakistanPress Release
Novel diagnostic technology enables powerful data intelligence, operational improvements and other enhancements in the lab RARITAN, New Jersey, July 25, 2018 /PRNewswire/ — Ortho Clinical Diagnostics today announced that it has received CE mark for Ortho’s VITROS® XT 7600 Integrated System. By combining Ortho’s proprietary dry slide technology with sophisticated...

Related Categorized Posts

استقالة الرئيسة التنفيذية لمؤسسة بيل ومليندا غيتس سو ديزموند هيلمان؛ تعيين العضو التنفيذي القديم في المؤسسة مارك سوزمان رئيسا تنفيذيا للمؤسسة
سياتل، 6 كانون الأول/ديسمبر، 2019 / بي آر نيوزواير / — أعلنت الرئيسة التنفيذية لمؤسسة بيل ومليندا غيتس سو ديزموند هيلمان تنحيها عن رئاسة المؤسسة بعد خمس سنوات من...

مستقبل يمكن توقعه: مجتمع العلوم والتقنية يعرب عن آمال كبيرة في التعاون مع الأتراب في الصين
بكين، 6 كانون الأول/ديسمبر، 2019 / بي آر نيوزواير / — يصادف حلول العام 2019 الذكرى السبعين لتأسيس جمهورية الصين الشعبية. وانتهزت مجلة العلوم والتكنولوجيا ديلي الفرصة لإجراء مقابلات...

‫مجموعة “جميرا” تضيف “كابري بالاس” في إيطاليا إلى قائمة فنادقها العالمية

‫مجموعة “جميرا” تضيف “كابري بالاس” في إيطاليا إلى قائمة فنادقها العالمية
 أعلنت مجموعة “جميرا”، الشركة العالمية الرائدة في إدارة الفنادق الفاخرة والتابعة لدبي القابضة، اليوم عن اختيارها لتشغيل وإدارة فندق “كابري بالاس” الشهير في إيطاليا. ولمشاهدة بيانات المالتى ميديا الصحفية...

مايندتري تنال جائزة اتحاد جنوب آسيا للمحاسبين عن أفضل تقرير سنوي مقدم

مايندتري تنال جائزة اتحاد جنوب آسيا للمحاسبين عن أفضل تقرير سنوي مقدم
 تكريم الشركة في فئة “قطاع الاتصالات وتقنية المعلومات” وارين، نيوجيرسي وبنغالور، الهند، 5 ديسمبر/كانون أول، 2019 /PRNewswire/ — حازت مايندتري “Mindtree“، الشركة العالمية الرائدة في مجال التقنية والتحول الرقمي،...

Bill & Melinda Gates Foundation CEO Sue Desmond-Hellmann to Step Down, Longtime Foundation Executive Mark Suzman Appointed to Role
SEATTLE, Dec. 5, 2019 /PRNewswire/ — Bill & Melinda Gates Foundation CEO Sue Desmond-Hellmann is stepping down after more than five years in the role. Bill and Melinda Gates have...